SMS Pharmaceuticals Ltd.
BSE: 532815 | Sector: Health care |
NSE: SMSPHARMA | ISIN Code: INE812G01025 |
BSE 00:00 | 20 Mar | 65.70 |
1.09 (1.69%) |
OPEN
61.20 |
HIGH
70.27 |
LOW
61.20 |
NSE 00:00 | 20 Mar | 65.90 |
1.45 (2.25%) |
OPEN
66.10 |
HIGH
69.85 |
LOW
63.40 |
OPEN | 61.20 |
PREVIOUS CLOSE | 64.61 |
VOLUME | 312409 |
52-Week high | 114.90 |
52-Week low | 60.10 |
P/E | 109.50 |
Mkt Cap.(Rs cr) | 556 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
SMS Pharmaceuticals Ltd. (SMSPHARMA) - Announcements
-
SMS Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
15/03/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
15/03/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript
14/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
10/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
10/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
09/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Investor Presentation
09/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Financial Results For The Quarter Ended 31St December 2022
09/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of Board Meeting And Financial Results
09/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08/02/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Board Meeting Intimation for Notice Of Board Meeting & Intimation
31/01/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09/01/2023 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
23/11/2022 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17/11/2022 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Investor Presentation On Q2 FY 2022-23
14/11/2022 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
14/11/2022 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half Year Ended 30Th Se
12/11/2022 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of The Board Meeting Held On 12-Nov-2022 To Consider Financial Sta
12/11/2022 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10/11/2022 | bse |
Downlaod PDF
-
SMS Pharmaceuticals Ltd Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Second Quarter And H
05/11/2022 | bse |
Downlaod PDF
Quick Links for SMS Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices